(1) Beginning April
1, 2025, and annually on or before April 1 of each year thereafter, each PBM
shall file with the Commissioner a written report that contains the following
information for the preceding calendar year on a form and in the manner
provided by the Commissioner, along with the review fee required under Rule
0780-01-95-.07(5):
(a) The total number of claims paid by the
PBM for prescription drugs or devices;
(b) The total number of claims paid by the
PBM to pharmacies physically located in Tennessee, or to mail order pharmacies
or specialty pharmacies on behalf of Tennessee residents, for prescription
drugs or devices;
(c) Descriptions
of all fees assessed by the PBM to pharmacies physically located in Tennessee,
mail order pharmacies that serve Tennessee residents, or specialty pharmacies
that serve Tennessee residents;
(d)
A schedule listing the unique identifier used by the PBM for internal
distribution and identification of each MAC list used for pharmacy
reimbursement at any point during the year for any pharmacy physically located
in Tennessee, any mail order pharmacy that served Tennessee residents, or any
specialty pharmacy that served Tennessee residents. For each MAC list, the PBM
must specify:
1. Each pharmacy network that
utilizes the MAC list as a basis for reimbursement, with each network
identified by the unique identifier provided in part (e)1.;
2. The policies, procedures, or criteria used
to determine which prescription drugs or devices are placed on the MAC list;
and
3. The policies, procedures, or
criteria used when updating the MAC list;
(e) A schedule of all the PBM's pharmacy
networks that contain pharmacies physically located in Tennessee, mail order
pharmacies that serve Tennessee residents, or specialty pharmacies that serve
Tennessee residents. For each network, the schedule must include the following
information:
1. The unique identifier of the
network used by the PBM for internal distribution and identification;
2. A description of the network's
purpose;
3. A schedule of all
pharmacies physically located in Tennessee, mail order pharmacies that serve
Tennessee residents, and specialty pharmacies that serve Tennessee residents
that were removed from the network, along with the following information for
each pharmacy removed;
(i) Pharmacy name and
national provider identifier; and
(ii) The name of the network from which the
applicant was removed; and
4. A schedule of denied network applications
received from pharmacies physically located in Tennessee, mail order pharmacies
that would have served Tennessee residents, or specialty pharmacies that would
have served Tennessee residents, along with the following information for each
application:
(i) Pharmacy name and national
provider identifier; and
(ii) The
name of the network into which the applicant was seeking entry;
(f) A schedule of all
pharmacies contracted with the PBM that are physically located in Tennessee,
mail order pharmacies that served Tennessee residents, or specialty pharmacies
that served Tennessee residents. For each pharmacy listed, provide the
following information:
1. Name and national
provider identifier;
2. Total
dollar amount of claims paid by the PBM to the pharmacy;
3. Total number of claims paid by the PBM to
the pharmacy;
4. The unique
identifier of the PBM's network(s) in which the pharmacy
participates;
5. The start and end
date(s) of all contracts with the pharmacy, including all amendments,
addendums, exhibits, provider manuals, and other documents that contain terms
or conditions material to the contractual relationship between the PBM and the
pharmacy;
6. Whether the pharmacy
is an affiliate of or shares any common ownership through a parent entity with
the PBM; and
7. Whether the
pharmacy certified as a low-volume pharmacy with the PBM pursuant to Rule
0780-01-95-.10 for any portion
of the calendar year;
(g)
1. A
complete schedule of pharmacy audits completed during the previous calendar
year for pharmacies physically located in Tennessee, mail order pharmacies that
served Tennessee residents, or specialty pharmacies that served Tennessee
residents, along with the following information on each completed audit:
(i) The name of the pharmacy audited and the
pharmacy's national provider identifier;
(ii) The start and completion date of the
audit;
(iii) Total number of claims
audited;
(iv) Preliminary
recoupment amount(s), if any; and
(v) Final recoupment amount(s), if
any.
2. For purposes of
this subparagraph (g), a PBM's audit of a pharmacy includes, but is not limited
to, activities by a PBM that may be described as periodic audits;
investigations; prescription validation requests; fraud, waste, and abuse
reviews; desktop audits; or other similar processes or reviews intended to
allow a PBM to inspect a pharmacy's internal records or processes;
(h) The number of initial appeals
filed with the PBM;
(i) The number
of initial appeals resolved in favor of pharmacies;
(j) The number of initial appeals resolved
against pharmacies;
(k) The total
amount of money paid to appealing pharmacies as a result of initial appeals
resolved in favor of pharmacies;
(l)
The total amount of money paid to similarly situated pharmacies as a result of
initial appeals resolved in favor of pharmacies;
(m) The number of initial appeals that were
appealed to the Commissioner of which the PBM received notice;
(n) A written statement certifying the PBM
meets the requirements of Rule
0780-01-95-.05(1)(c)
along with timestamped screenshots of the PBM's website showing the required
information is on the PBM's website and is readily accessible by pharmacies;
and
(o) Any other documentation or
information requested by the Commissioner.
(2) PBMs may exclude information from the
report required under paragraph (1) if the information pertains exclusively to
plans in T.C.A. § 56-7-3102(1)(B).
(3) On or before August 1, 2024, each PBM
shall file with the Commissioner a written report that contains the information
required under subparagraphs (h) through (o) of paragraph (1) for calendar year
2023 on a form and in the manner provided by the Commissioner, along with the
review fee required under Rule
0780-01-95-.07(5).
(4) The Commissioner may extend a PBM's
deadline for filing its annual report for good cause shown.
(5)
(a) A
PBM may redact information from its annual report that is confidential or
proprietary information or a trade secret as those terms, or substantially
similar terms as determined by the Department, are defined in Tennessee or
federal law. Upon request from the Commissioner, a PBM shall provide the
specific authority and rationale on which it based its determination that
redacted information is confidential or proprietary or a trade
secret.
(b) A PBM shall not redact
information from annual reports pursuant to subparagraph (a) as confidential or
proprietary information or trade secrets if such information is confidential
under Tennessee or federal law such that the Department determines it is not
available for public inspection while in the Department's possession.